D-0519-2020 Class III Terminated

Recalled by X-Gen Pharmaceuticals Inc. — Horseheads, NY

FDA drug recall D-0519-2020 was initiated by X-Gen Pharmaceuticals Inc. on Oct 11, 2019 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached. The recall status is terminated (terminated Aug 16, 2022). Affected quantity: 25120 vials.

Recall details

Product Type
Drugs
Report Date
Nov 27, 2019
Initiation Date
Oct 11, 2019
Termination Date
Aug 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25120 vials

Product description

Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manufactured by: Agile Specialties Private Limited Pilot No. 14, Sipcot II, Hosur-635 109 Tamil Nadu, India, Manufactured for: X-Gen Pharmaceuticals, Inc. Big Flats, NY 14814, NDC 39822-4000-1

Reason for recall

Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: 7603333, 7603334, 7603335, Exp 05/2020; 7051107, Exp 01/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0519-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0519-2020. Report a data issue: hello@regdatalab.com.